Table A9.
Genotype | Clinical Benefit |
||
---|---|---|---|
No. | % | 95% CI | |
Exon 9 (n = 3) | 2 | 66.7 | 9.4 to 99.2 |
Exon 11 (n = 19) | 16 | 84.2 | 60.4 to 96.6 |
Wild type (n = 8) | 6 | 75.0 | 34.9 to 96.8 |
NOTE. There was no statistically significant difference in clinical benefit rate in different GI stromal tumor genotype groups using Fisher's exact test.